Novavax likely won't file for emergency use authorization with the FDA for its COVID-19 vaccine until June, four people familiar with the matter told The Washington Post.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,